Annual Working Capital
$22.61 M
-$43.72 M-65.91%
31 December 2023
Summary:
Candel Therapeutics annual working capital is currently $22.61 million, with the most recent change of -$43.72 million (-65.91%) on 31 December 2023. During the last 3 years, it has fallen by -$7.82 million (-25.70%). CADL annual working capital is now -71.59% below its all-time high of $79.58 million, reached on 31 December 2021.CADL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$2.82 M
-$5.92 M-67.77%
30 September 2024
Summary:
Candel Therapeutics quarterly working capital is currently $2.82 million, with the most recent change of -$5.92 million (-67.77%) on 30 September 2024. Over the past year, it has dropped by -$31.96 million (-91.90%). CADL quarterly working capital is now -96.88% below its all-time high of $90.17 million, reached on 31 March 2022.CADL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CADL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.9% | -91.9% |
| 3 y3 years | -25.7% | -96.8% |
| 5 y5 years | - | - |
CADL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -71.6% | at low | -96.9% | at low |
| 5 y | 5 years | -71.6% | at low | -96.9% | at low |
| alltime | all time | -71.6% | at low | -96.9% | at low |
Candel Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.82 M(-67.8%) |
| June 2024 | - | $8.74 M(-35.7%) |
| Mar 2024 | - | $13.60 M(-39.9%) |
| Dec 2023 | $22.61 M(-65.9%) | $22.61 M(-35.0%) |
| Sept 2023 | - | $34.77 M(-23.1%) |
| June 2023 | - | $45.20 M(-20.2%) |
| Mar 2023 | - | $56.64 M(-14.6%) |
| Dec 2022 | $66.33 M | $66.33 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $73.17 M(-10.2%) |
| June 2022 | - | $81.45 M(-9.7%) |
| Mar 2022 | - | $90.17 M(+13.3%) |
| Dec 2021 | $79.58 M(+161.5%) | $79.58 M(-8.1%) |
| Sept 2021 | - | $86.55 M(+334.2%) |
| June 2021 | - | $19.93 M(-16.9%) |
| Mar 2021 | - | $23.97 M(-21.2%) |
| Dec 2020 | $30.43 M(-30.5%) | $30.43 M |
| Dec 2019 | $43.80 M | - |
FAQ
- What is Candel Therapeutics annual working capital?
- What is the all time high annual working capital for Candel Therapeutics?
- What is Candel Therapeutics annual working capital year-on-year change?
- What is Candel Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Candel Therapeutics?
- What is Candel Therapeutics quarterly working capital year-on-year change?
What is Candel Therapeutics annual working capital?
The current annual working capital of CADL is $22.61 M
What is the all time high annual working capital for Candel Therapeutics?
Candel Therapeutics all-time high annual working capital is $79.58 M
What is Candel Therapeutics annual working capital year-on-year change?
Over the past year, CADL annual working capital has changed by -$43.72 M (-65.91%)
What is Candel Therapeutics quarterly working capital?
The current quarterly working capital of CADL is $2.82 M
What is the all time high quarterly working capital for Candel Therapeutics?
Candel Therapeutics all-time high quarterly working capital is $90.17 M
What is Candel Therapeutics quarterly working capital year-on-year change?
Over the past year, CADL quarterly working capital has changed by -$31.96 M (-91.90%)